Molteni Therapeutics products are made to sustain and improve the patient’s quality of life, to help physicians in the clinical practices, to meet the unmet medical needs
Molteni Therapeutics Receives CE Mark for Its New Product VULNOFAST® gel
Florence, March 2013
Florence (Italy) – Molteni Therapeutics Srl announced that it received CE Mark* approval for its new product VULNOFAST® gel. VULNOFAST® gel is a sterile device used as an adjuvant for the local treatment of wounds and skin ulcers.
* The CE Mark indicates that the product satisfies requirements of EU Directives (EU: The European Union) and all products need to be CE certified to be sold in Europe.